358 related articles for article (PubMed ID: 30104277)
1. Activity of Aromathecins against African Trypanosomes.
Nenortas NP; Cinelli MA; Morrell AE; Cushman M; Shapiro TA
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30104277
[TBL] [Abstract][Full Text] [Related]
2. Newly identified antibacterial compounds are topoisomerase poisons in African trypanosomes.
Tang SC; Shapiro TA
Antimicrob Agents Chemother; 2010 Feb; 54(2):620-6. PubMed ID: 20008775
[TBL] [Abstract][Full Text] [Related]
3. Anti-trypanosomal activities of DNA topoisomerase inhibitors.
Deterding A; Dungey FA; Thompson KA; Steverding D
Acta Trop; 2005 Mar; 93(3):311-6. PubMed ID: 15715983
[TBL] [Abstract][Full Text] [Related]
4. Discovery of 2-(1H-imidazo-2-yl)piperazines as a new class of potent and non-cytotoxic inhibitors of Trypanosoma brucei growth in vitro.
Ferrigno F; Biancofiore I; Malancona S; Ponzi S; Paonessa G; Graziani R; Bresciani A; Gennari N; Di Marco A; Kaiser M; Summa V; Harper S; Ontoria JM
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3689-3692. PubMed ID: 30482621
[TBL] [Abstract][Full Text] [Related]
5. 9- and 11-Substituted 4-azapaullones are potent and selective inhibitors of African trypanosoma.
Maiwald F; Benítez D; Charquero D; Dar MA; Erdmann H; Preu L; Koch O; Hölscher C; Loaëc N; Meijer L; Comini MA; Kunick C
Eur J Med Chem; 2014 Aug; 83():274-83. PubMed ID: 24973661
[TBL] [Abstract][Full Text] [Related]
6. The kinetoplastid chemotherapy revisited: current drugs, recent advances and future perspectives.
Castillo E; Dea-Ayuela MA; Bolás-Fernández F; Rangel M; González-Rosende ME
Curr Med Chem; 2010; 17(33):4027-51. PubMed ID: 20939823
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel inhibitors of UDP-Glc 4'-epimerase, a validated drug target for african sleeping sickness.
Urbaniak MD; Tabudravu JN; Msaki A; Matera KM; Brenk R; Jaspars M; Ferguson MA
Bioorg Med Chem Lett; 2006 Nov; 16(22):5744-7. PubMed ID: 16962325
[TBL] [Abstract][Full Text] [Related]
8. Sleeping sickness pathogen (Trypanosoma brucei) and natural products: therapeutic targets and screening systems.
Hannaert V
Planta Med; 2011 Apr; 77(6):586-97. PubMed ID: 20945274
[TBL] [Abstract][Full Text] [Related]
9. Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis.
Jones AJ; Kaiser M; Avery VM
Antimicrob Agents Chemother; 2015 Dec; 60(3):1859-61. PubMed ID: 26666915
[TBL] [Abstract][Full Text] [Related]
10. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
[TBL] [Abstract][Full Text] [Related]
11. Optimization of physicochemical properties for 4-anilinoquinazoline inhibitors of trypanosome proliferation.
Woodring JL; Bachovchin KA; Brady KG; Gallerstein MF; Erath J; Tanghe S; Leed SE; Rodriguez A; Mensa-Wilmot K; Sciotti RJ; Pollastri MP
Eur J Med Chem; 2017 Dec; 141():446-459. PubMed ID: 29049963
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapeutic strategies against Trypanosoma brucei: drug targets vs. drug targeting.
Lüscher A; de Koning HP; Mäser P
Curr Pharm Des; 2007; 13(6):555-67. PubMed ID: 17346174
[TBL] [Abstract][Full Text] [Related]
13. New heterocyclic compounds: Synthesis and antitrypanosomal properties.
Pomel S; Dubar F; Forge D; Loiseau PM; Biot C
Bioorg Med Chem; 2015 Aug; 23(16):5168-74. PubMed ID: 25835356
[TBL] [Abstract][Full Text] [Related]
14. Potent antitrypanosomal activities of heat shock protein 90 inhibitors in vitro and in vivo.
Meyer KJ; Shapiro TA
J Infect Dis; 2013 Aug; 208(3):489-99. PubMed ID: 23630365
[TBL] [Abstract][Full Text] [Related]
15. Activity of indenoisoquinolines against African trypanosomes.
Bakshi RP; Sang D; Morrell A; Cushman M; Shapiro TA
Antimicrob Agents Chemother; 2009 Jan; 53(1):123-8. PubMed ID: 18824603
[TBL] [Abstract][Full Text] [Related]
16. Screening of acyl hydrazide proteinase inhibitors for antiparasitic activity against Trypanosoma brucei.
Caffrey CR; Schanz M; Nkemngu NJ; Brush M; Hansell E; Cohen FE; Flaherty TM; McKerrow JH; Steverding D
Int J Antimicrob Agents; 2002 Mar; 19(3):227-31. PubMed ID: 11932146
[TBL] [Abstract][Full Text] [Related]
17. [Prophylactic and curative action of Ridzol-S and Ronidazole in experimental trypanosomiasis caused by Trypanosoma brucei et T. evansi].
Tchalim TK
Ann Soc Belg Med Trop; 1980 Sep; 60(3):263-70. PubMed ID: 7195691
[No Abstract] [Full Text] [Related]
18. Novel distamycin analogues that block the cell cycle of African trypanosomes with high selectivity and potency.
Franco J; Scarone L; Comini MA
Eur J Med Chem; 2020 Mar; 189():112043. PubMed ID: 31978782
[TBL] [Abstract][Full Text] [Related]
19. Diamidine activity against trypanosomes: the state of the art.
Soeiro MN; de Castro SL; de Souza EM; Batista DG; Silva CF; Boykin DW
Curr Mol Pharmacol; 2008 Jun; 1(2):151-61. PubMed ID: 20021429
[TBL] [Abstract][Full Text] [Related]
20. The biochemistry of African trypanosomes and its significance for chemotherapy.
Braide VB
J Vet Pharmacol Ther; 1987 Sep; 10(3):191-201. PubMed ID: 3309362
[No Abstract] [Full Text] [Related]
[Next] [New Search]
